Fernandes C, Arnot M I, Irvine E E, Bateson A N, Martin I L, File S E
Psychopharmacology Research Unit, GKT School of Biomedical Sciences, King's College London, UK.
Psychopharmacology (Berl). 1999 Aug;145(3):251-9. doi: 10.1007/s002130051056.
Chronic treatment with benzodiazepines results in tolerance to their sedative and anxiolytic effects and there is considerable evidence that different mechanisms underlie the development of tolerance to different behavioural effects.
The purpose of the present experiment was to compare the behavioural effects of chronic treatment with diazepam (15 mg/kg per day) given as daily subcutaneous injections or by osmotic minipump. Both regimens resulted in continual receptor occupancy, but the daily injections also provided a period of higher brain concentrations.
Rats were tested in the holeboard, which provides measures of exploration and locomotor activity, and in the elevated plus-maze and social interaction tests of anxiety. For those in the subcutaneous injection group the tests were 2 h after injection, when brain concentrations were highest.
Despite a higher brain concentration in the injected group, both groups showed tolerance to diazepam's sedative effects, after 7 days of treatment. In contrast, in the elevated plus-maze, there was tolerance to the anxiolytic effects in the pump group after 14 days, but a persisting anxiolytic effect in the injected group at 14 and 28 days. Whilst higher brain concentrations could explain this result in the plus-maze, they cannot account for the pattern observed in the social interaction test, where the injection group showed a significant anxiogenic effect at 28 days.
Whereas the mechanism underlying tolerance to the sedative effects of diazepam was insensitive to the different treatment regimens, the results suggest that different adaptive mechanisms were triggered in the two tests of anxiety with a differential sensitivity to the treatment regimen. The adaptive mechanism predominating in the social interaction test was favoured by the injection regimen which produced intermittent peak concentrations. This mechanism seems to be an oppositional one, leading to an anxiogenic response, which was manifest despite high brain concentrations of diazepam at the time of testing.
长期使用苯二氮䓬类药物会导致机体对其镇静和抗焦虑作用产生耐受性,并且有大量证据表明,对不同行为效应产生耐受性的机制各不相同。
本实验旨在比较每天皮下注射或通过渗透微型泵给予地西泮(15毫克/千克/天)进行长期治疗的行为效应。两种给药方案均导致受体持续占据,但每日注射还会使大脑在一段时间内处于较高浓度状态。
对大鼠进行洞板试验(该试验可测量探索和运动活动)、高架十字迷宫试验以及焦虑的社交互动试验。对于皮下注射组的大鼠,试验在注射后2小时进行,此时大脑浓度最高。
尽管注射组的大脑浓度较高,但在治疗7天后,两组均对地西泮的镇静作用产生了耐受性。相比之下,在高架十字迷宫试验中,泵注组在14天后对其抗焦虑作用产生了耐受性,但注射组在14天和28天时仍存在持续的抗焦虑作用。虽然较高的大脑浓度可以解释高架十字迷宫试验中的这一结果,但却无法解释社交互动试验中观察到的模式,在社交互动试验中,注射组在28天时表现出显著的致焦虑效应。
尽管地西泮镇静作用耐受性的潜在机制对不同治疗方案不敏感,但结果表明,在两项焦虑试验中触发了不同的适应性机制,且对治疗方案的敏感性存在差异。注射方案产生间歇性峰值浓度,有利于社交互动试验中占主导地位的适应性机制。这种机制似乎是一种对立机制,会导致致焦虑反应,尽管在测试时大脑中地西泮浓度很高,但该反应仍然明显。